These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3197580)

  • 41. [Drugs affecting upper respiratory tract motility: cisapride].
    Dallera F; Scanzi G; Gendarini A
    Recenti Prog Med; 1992 Mar; 83(3):145-6. PubMed ID: 1585033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contractile mechanisms of action of gastroprokinetic agents: cisapride, metoclopramide, and domperidone.
    Orihata M; Sarna SK
    Am J Physiol; 1994 Apr; 266(4 Pt 1):G665-76. PubMed ID: 8179003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of cisapride on gastric motility.
    Schuurkes J
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():27-30; discussion 44. PubMed ID: 2356634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of prostaglandin F2alpha and cisapride on small intestinal activity during the early postoperative period in humans.
    Shibata Y; Toyoda S
    Surg Today; 1998; 28(8):787-91. PubMed ID: 9718997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT; Lee YJ; Chung SJ; Shim CK
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of cisapride on elemental content in neonatal mouse small intestine in vivo.
    Spencer AJ; Osborne MP; Stephen J
    Eur J Pharmacol; 1996 May; 303(3):205-8. PubMed ID: 8813569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of sphincter of Oddi spike bursts to gastrointestinal myoelectric activity in conscious opossums.
    Honda R; Toouli J; Dodds WJ; Sarna S; Hogan WJ; Itoh Z
    J Clin Invest; 1982 Apr; 69(4):770-8. PubMed ID: 7076847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.
    McCallum RW; Prakash C; Campoli-Richards DM; Goa KL
    Drugs; 1988 Dec; 36(6):652-81. PubMed ID: 3065057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisapride increases gastric emptying without affecting small or large bowel transit.
    Williams CL; Burks TF
    Proc West Pharmacol Soc; 1985; 28():47-50. PubMed ID: 3840899
    [No Abstract]   [Full Text] [Related]  

  • 51. Placebo-controlled trial of cisapride in postoperative ileus.
    Boghaert A; Haesaert G; Mourisse P; Verlinden M
    Acta Anaesthesiol Belg; 1987; 38(3):195-9. PubMed ID: 3321849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects.
    Edwards CA; Holden S; Brown C; Read NW
    Gut; 1987 Jan; 28(1):13-6. PubMed ID: 3817579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of cisapride on upper-gastrointestinal motility and digestive hormones].
    Abe S; Furukawa Y; Nakata K; Morita M; Ohira Y; Haneu Y; Aoki T
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):73-8. PubMed ID: 2273690
    [No Abstract]   [Full Text] [Related]  

  • 54. Relationships between electromyographic ileal and colonic motility patterns in cats during fasting and feeding.
    Cherbut C; Achard F; Denavit M; Roche M
    Can J Vet Res; 1986 Jan; 50(1):106-10. PubMed ID: 3742348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of the long-acting somatostatin analogue SMS 201-995 on small-intestinal interdigestive motility in the dog.
    Peeters TL; Romanski KW; Janssens J; Vantrappen G
    Scand J Gastroenterol; 1988 Sep; 23(7):769-74. PubMed ID: 3227290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of orally administered cisapride on intestinal motility in conscious horses.
    Sasaki N; Yoshihara T
    J Vet Med Sci; 2000 Feb; 62(2):211-3. PubMed ID: 10720195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder.
    Camilleri M; Balm RK; Zinsmeister AR
    Gastroenterology; 1994 Apr; 106(4):916-23. PubMed ID: 8143996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antroduodenal coordination].
    Lux G; Lederer P; Ellermann A
    Z Gastroenterol; 1986 Sep; 24 Suppl 2():55-61. PubMed ID: 3776267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cisapride: a gastrointestinal prokinetic drug.
    Barone JA; Jessen LM; Colaizzi JL; Bierman RH
    Ann Pharmacother; 1994 Apr; 28(4):488-500. PubMed ID: 8038476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in antroduodenal resistance induced by Cisapride in conscious dogs.
    Malbert CH; Serthelon JP; Dent J
    Am J Physiol; 1992 Aug; 263(2 Pt 1):G202-8. PubMed ID: 1514631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.